VISIT OUR COVID-19 HUB
Aiming for Equity
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
TRANSLATING TECHNICAL LANGUAGE INTO PLAIN LANGUAGE FOR CLINICAL TRIALS

Your search for a clinical trial starts here.
Learn more about the process of joining a clinical trial and find a trial near you.
LEARN ABOUT OUR CLINICAL TRIAL FOR PEOPLE RECENTLY DIAGNOSED WITH COVID-19
A NEW PARTNERSHIP THAT TARGETS RARE DISEASE
Latest News
-JADE DARE trial met co-primary and key secondary endpoints and demonstrated a safety profile consistent with previous studies- Pfizer Inc. (NYSE: PFE) today announced that JADE DARE (B7451050), a 26-week, randomized, double-blind, double-dummy, active-controlled, multi-center Phase 3 study, met its co-primary and key secondary efficacy endpoints. The study showed that abrocitinib was statistically superior compared to dupilumab in each evaluated efficacy measure and had a safety profile…











